Novelion Therapeutics Inc (NVLNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Operating Expenses | 10,737 | 6,015 | -17,920 | 5,402 | 8,578 |
| Operating Income | -10,737 | -6,015 | 17,920 | -5,402 | -8,578 |
| Other Income | -9 | 128 | -1,954 | 44 | 20 |
| Pre-tax Income | -10,746 | -5,887 | 15,966 | -5,358 | -8,558 |
| Income Tax | 5 | 9 | 2 | -432 | 23 |
| Net Income Continuous | -10,751 | -5,896 | 15,964 | -4,926 | -8,581 |
| Net Income Discontinuous | N/A | N/A | -3 | -6 | -57 |
| Net Income | $-10,751 | $-5,896 | $15,961 | $-4,932 | $-8,638 |
| EPS Basic Total Ops | -1.05 | -0.60 | 1.60 | -0.50 | -0.85 |
| EPS Basic Continuous Ops | -1.04 | -0.58 | 1.58 | -0.48 | -0.85 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.00 | 0.00 | -0.01 |
| EPS Diluted Total Ops | -1.05 | -0.60 | 1.60 | -0.50 | -0.85 |
| EPS Diluted Continuous Ops | -1.04 | -0.58 | 1.58 | -0.48 | -0.85 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.00 | 0.00 | -0.01 |
| EBITDA(a) | $-10,558 | $-5,827 | $18,131 | $-5,180 | $-8,349 |